Altered endothelial function following the Fontan procedure
- PMID: 18093358
- DOI: 10.1017/S1047951107001680
Altered endothelial function following the Fontan procedure
Abstract
Objective: Thrombosis has been widely described after the Fontan procedure. The vascular endothelium plays a central role in the control of coagulation and fibrinolysis. The aim of this study was to investigate if patients undergoing a modified Fontan procedure have impaired endothelial function and fibrinolysis in the late postoperative course.
Patients and methods: We compared 23 patients aged from 7 to 26 years with age-matched healthy volunteers, collecting blood samples prior to and following standardized venous occlusion testing. Plasma levels of von Willebrand factor antigen, tissue-type plasminogen activator antigen, plasminogen activator inhibitor-1, and D-dimer were measured with enzyme-linked immunosorbent assay.
Results: We found increased plasma levels of von Willebrand factor antigen in patients when compared to controls (p = 0.003). At the basal condition, concentrations of tissue-type plasminogen activator antigen and plasminogen activator inhibitor-1 antigen in the plasma, as well as their activity, were not significantly different between patients and controls. Following venous occlusion, concentrations of tissue-type plasminogen activator antigen in the plasma were significantly increased both in patients and controls, compared to pre-occlusion values. D-dimer was within the reference range. Multivariate discriminant analysis differentiated patients and their controls on the basis of differences for plasminogen activator inhibitor-1 and von Willebrand factor antigen (p = 0.0016).
Conclusions: Our data suggest that patients with the Fontan circulation may have endothelial dysfunction, as indicated by raised levels of von Willebrand factor. Fibrinolysis seems to be relatively preserved, as suggested by appropriate response to venous occlusion.
Similar articles
-
Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation.Cardiol Young. 2005 Feb;15(1):26-30. doi: 10.1017/S1047951105000065. Cardiol Young. 2005. PMID: 15831157
-
Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.Blood Coagul Fibrinolysis. 2007 Jul;18(5):395-9. doi: 10.1097/MBC.0b013e328133f70f. Blood Coagul Fibrinolysis. 2007. PMID: 17581312 Clinical Trial.
-
von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.J Lab Clin Med. 1992 Sep;120(3):411-9. J Lab Clin Med. 1992. PMID: 1517688
-
Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease.J Am Coll Cardiol. 2010 Jun 15;55(24):2701-9. doi: 10.1016/j.jacc.2009.11.095. J Am Coll Cardiol. 2010. PMID: 20538163 Review.
-
Endothelial dysfunction in the pathogenesis of atherosclerosis.Int Angiol. 2002 Jun;21(2):109-16. Int Angiol. 2002. PMID: 12110769 Review.
Cited by
-
Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.Circ Heart Fail. 2017 Dec;10(12):e004515. doi: 10.1161/CIRCHEARTFAILURE.117.004515. Circ Heart Fail. 2017. PMID: 29246897 Free PMC article.
-
Intermediate term thrombotic risk in contemporary total cavo-pulmonary connection for single ventricle circulations.J Thromb Thrombolysis. 2017 Oct;44(3):275-280. doi: 10.1007/s11239-017-1530-0. J Thromb Thrombolysis. 2017. PMID: 28761995
-
Optimizing Computed Tomography for Detection of Pulmonary Thromboembolism in Patients With Fontan Circulation.Cureus. 2020 May 28;12(5):e8326. doi: 10.7759/cureus.8326. Cureus. 2020. PMID: 32499987 Free PMC article.
-
Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.J Am Heart Assoc. 2021 Feb;10(5):e015022. doi: 10.1161/JAHA.119.015022. Epub 2021 Feb 24. J Am Heart Assoc. 2021. PMID: 33624507 Free PMC article.
-
Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.Pediatr Cardiol. 2013 Feb;34(2):262-72. doi: 10.1007/s00246-012-0431-4. Epub 2012 Jul 28. Pediatr Cardiol. 2013. PMID: 22843202
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical